Loading...

Robert Mahley, MD, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPathology
Address
Phone415-734-2062
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Areas of Investigation
    The major focus of our laboratory is to elucidate the function of apolipoprotein (apo) E in both cardiovascular disease and neurobiology. We are especially interested in determining the basis of the differential effects of the apoE isoforms (apoE2, E3, and E4) in neuronal repair/remodeling, in neuroprotection, and in defining how apoE4 causes neuropathology.

    Significance
    ApoE is produced in abundance in the brain and serves as the principal lipid transport vehicle in cerebrospinal fluid. ApoE4 is a major gene associated with 60–70% of cases of sporadic and familial Alzheimer’s disease. ApoE4 increases the occurrence and lowers the age of onset of Alzheimer’s disease and is also associated with poor clinical outcome in patients with traumatic brain injury. Defining the effects of the three apoE isoforms on the structure and function of the brain is providing crucial insights into the contribution of apoE4 to neurological disease, and providing a way forward for treating Alzheimer’s disease and other apoE4-associated neurodegenerative disorders.

    Approaches
    We use biophysical techniques in combination with cell and molecular biology, and transgenic and gene knockout mice to study the molecular mechanisms involving apoE in normal development and disease, including Alzheimer’s disease and other neurodegenerative diseases. Medicinal chemistry is used to identify small molecules that modulate the structure of the apoE4.

    Contributions
    My laboratory described apoE’s receptor ligand function, determined its protein and gene sequences, mapped the amino acid residues involved in receptor binding, and defined the three-dimensional structure of the ligand-binding domain. Understanding the structure and function of apoE laid the groundwork for the recent explosion of studies concerning apoE4 and Alzheimer’s disease. My laboratory was involved in describing the role of apoE in lipid transport in the nervous system, modulation of mitochondrial activity, and cytoskeletal stability involving normal and pathological CNS metabolism. By establishing brain-specific apoE transgenic mice, we demonstrated detrimental effects on apoE4 on the central nervous system in vivo and described a mechanism whereby apoE4 is involved in neuropathology.

    Research Summary
    Apolipoprotein (apo) E was initially described as a lipid transport protein and major ligand for low density lipoprotein (LDL) receptors with a role in cholesterol metabolism and cardiovascular disease. It has since emerged as a major risk factor (causative gene) for Alzheimer’s disease and other neurodegenerative disorders. Detailed understanding of the structural features of the three isoforms (apoE2, apoE3, and apoE4), which differ by only a single amino acid interchange, has elucidated their unique functions. ApoE2 and apoE4 increase the risk for heart disease: apoE2 increases atherogenic lipoprotein levels (it binds poorly to LDL receptors) and apoE4 increases LDL levels (it binds preferentially to triglyceride-rich, very low density lipoproteins, leading to downregulation of LDL receptors). ApoE4 also increases the risk for neurodegenerative diseases, decreases their age of onset, or alters their progression. ApoE4 likely causes neurodegeneration secondary to its abnormal structure, caused by an interaction between its carboxyl- and amino-terminal domains, called domain interaction. When neurons are stressed or injured, they synthesize apoE to redistribute cholesterol for neuronal repair or remodeling. However, because of its altered structure, neuronal apoE4 undergoes neuron-specific proteolysis, generating neurotoxic fragments (12–29-kDa) that escape the secretory pathway and cause mitochondrial dysfunction and cytoskeletal alterations, including tau phosphorylation. ApoE4-associated pathology can be prevented by small-molecule structure correctors that block domain interaction by converting apoE4 to a molecule that resembles apoE3 both structurally and functionally. Structure correctors are a potential therapeutic approach to reduce apoE4 pathology in both cardiovascular and neurological disorders.


    Collapse Research 
    Collapse Research Activities and Funding
    Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
    NIH/NIA U01AG043394Sep 30, 2012 - Aug 31, 2017
    Role: Principal Investigator
    ApoE4 Structure Correctors as a Therapeutic Approach for Alzheimers Disease
    NIH/NIDA R03DA034595May 1, 2012 - Apr 30, 2014
    Role: Principal Investigator
    Role of apoE structure and metabolism in neurodegeneration
    NIH/NIA R01AG028793Mar 1, 2008 - Feb 28, 2014
    Role: Principal Investigator
    EXTRAMULAR RESEARCH FACILITIES CONSTRUCTION
    NIH/NCRR C06RR018928Sep 15, 2003 - Sep 14, 2005
    Role: Principal Investigator
    Targeting Apolipoprotein E4-related Neuropathology
    NIH/NINDS R21NS046465Jul 1, 2003 - Jun 30, 2006
    Role: Principal Investigator
    Genetic Determinants: Low HDL, High Triglycerides, Obes*
    NIH/NHLBI R01HL071027Apr 1, 2002 - Mar 31, 2004
    Role: Principal Investigator
    GENETIC ALTERATIONS ON LIPOPROTEINS AND ATHEROSCLEROSIS
    NIH/NHLBI P01HL047660Sep 30, 1992 - Aug 31, 2003
    Role: Principal Investigator
    SMALL INSTRUMENTATION GRANT
    NIH/NHLBI S15HL049381Sep 1, 1992 - Aug 31, 1993
    Role: Principal Investigator
    LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM
    NIH/NHLBI P01HL041633Feb 1, 1989 - Jan 31, 2005
    Role: Co-Principal Investigator
    NHLBI SHARED RESEARCH FACILITY FOR MOLECULAR BIOLOGY
    NIH/NHLBI C06HL039962Sep 30, 1987 - Sep 29, 1993
    Role: Principal Investigator
    BIOMEDICAL RESEARCH SUPPORT GRANT
    NIH/NCRR S07RR005880Apr 1, 1983 - Sep 29, 1992
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mahley R. Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases. Clin Chem. 2017 Jan; 63(1):14-20. PMID: 28062606.
      View in: PubMed
    2. Mallick S, Li H, Lipson M, Mathieson I, Gymrek M, Racimo F, Zhao M, Chennagiri N, Nordenfelt S, Tandon A, Skoglund P, Lazaridis I, Sankararaman S, Fu Q, Rohland N, Renaud G, Erlich Y, Willems T, Gallo C, Spence JP, Song YS, Poletti G, Balloux F, van Driem G, de Knijff P, Romero IG, Jha AR, Behar DM, Bravi CM, Capelli C, Hervig T, Moreno-Estrada A, Posukh OL, Balanovska E, Balanovsky O, Karachanak-Yankova S, Sahakyan H, Toncheva D, Yepiskoposyan L, Tyler-Smith C, Xue Y, Abdullah MS, Ruiz-Linares A, Beall CM, Di Rienzo A, Jeong C, Starikovskaya EB, Metspalu E, Parik J, Villems R, Henn BM, Hodoglugil U, Mahley R, Sajantila A, Stamatoyannopoulos G, Wee JT, Khusainova R, Khusnutdinova E, Litvinov S, Ayodo G, Comas D, Hammer MF, Kivisild T, Klitz W, Winkler CA, Labuda D, Bamshad M, Jorde LB, Tishkoff SA, Watkins WS, Metspalu M, Dryomov S, Sukernik R, Singh L, Thangaraj K, Pääbo S, Kelso J, Patterson N, Reich D. The Simons Genome Diversity Project: 300 genomes from 142 diverse populations. Nature. 2016 Oct 13; 538(7624):201-206. PMID: 27654912.
      View in: PubMed
    3. Mahley R, et al. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016 Jul; 94(7):739-46. PMID: 27277824; PMCID: PMC4921111.
    4. Mahley R. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol. 2016 Jul; 36(7):1305-15. PMID: 27174096; PMCID: PMC4942259.
    5. Lazaridis I, Patterson N, Mittnik A, Renaud G, Mallick S, Kirsanow K, Sudmant PH, Schraiber JG, Castellano S, Lipson M, Berger B, Economou C, Bollongino R, Fu Q, Bos KI, Nordenfelt S, Li H, de Filippo C, Prüfer K, Sawyer S, Posth C, Haak W, Hallgren F, Fornander E, Rohland N, Delsate D, Francken M, Guinet JM, Wahl J, Ayodo G, Babiker HA, Bailliet G, Balanovska E, Balanovsky O, Barrantes R, Bedoya G, Ben-Ami H, Bene J, Berrada F, Bravi CM, Brisighelli F, Busby GB, Cali F, Churnosov M, Cole DE, Corach D, Damba L, van Driem G, Dryomov S, Dugoujon JM, Fedorova SA, Gallego Romero I, Gubina M, Hammer M, Henn BM, Hervig T, Hodoglugil U, Jha AR, Karachanak-Yankova S, Khusainova R, Khusnutdinova E, Kittles R, Kivisild T, Klitz W, Kucinskas V, Kushniarevich A, Laredj L, Litvinov S, Loukidis T, Mahley R, Melegh B, Metspalu E, Molina J, Mountain J, Näkkäläjärvi K, Nesheva D, Nyambo T, Osipova L, Parik J, Platonov F, Posukh O, Romano V, Rothhammer F, Rudan I, Ruizbakiev R, Sahakyan H, Sajantila A, Salas A, Starikovskaya EB, Tarekegn A, Toncheva D, Turdikulova S, Uktveryte I, Utevska O, Vasquez R, Villena M, Voevoda M, Winkler CA, Yepiskoposyan L, Zalloua P, Zemunik T, Cooper A, Capelli C, Thomas MG, Ruiz-Linares A, Tishkoff SA, Singh L, Thangaraj K, Villems R, Comas D, Sukernik R, Metspalu M, Meyer M, Eichler EE, Burger J, Slatkin M, Pääbo S, Kelso J, Reich D, Krause J. Ancient human genomes suggest three ancestral populations for present-day Europeans. Nature. 2014 Sep 18; 513(7518):409-13. PMID: 25230663; PMCID: PMC4170574.
    6. Huang Y, Mahley R. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis. 2014 Dec; 72 Pt A:3-12. PMID: 25173806; PMCID: PMC4253862.
    7. Mahley R. Shinya Yamanaka, M.D., Ph.D. - 2012 Nobel Prize Laureate: how his dream of a research career provides vision for the next generation of young scientists. Anadolu Kardiyol Derg. 2013 May; 13(3):204-6. PMID: 23618992.
      View in: PubMed
    8. Mahley R, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012 Dec 06; 76(5):871-85. PMID: 23217737; PMCID: PMC4891195.
    9. Mahley R, Huang Y. Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology. J Med Chem. 2012 Nov 08; 55(21):8997-9008. PMID: 23013167; PMCID: PMC4904786.
    10. Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley R, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement. 2012 Sep; 8(5):445-52. PMID: 22959699; PMCID: PMC3552530.
    11. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Kähönen M, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, Böhringer S, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Lehtimäki T, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Barroso I, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8(3):e1002607. PMID: 22479202; PMCID: PMC3315470.
    12. Hodoglugil U, Mahley R. Turkish population structure and genetic ancestry reveal relatedness among Eurasian populations. Ann Hum Genet. 2012 Mar; 76(2):128-41. PMID: 22332727; PMCID: PMC4904778.
    13. Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN, Bostrom MA, Rudock ME, Talbert ME, Lewis JP, Ferrara A, Lu L, Ziegler JT, Sale MM, Divers J, Shriner D, Adeyemo A, Rotimi CN, Ng MC, Langefeld CD, Freedman BI, Bowden DW, Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Couper DJ, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Klopp N, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Perry JR, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Mohlke KL, Morris AD, Palmer CN, Pramstaller PP, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS, Pedersen O, Wichmann HE, Barroso I, Florez JC, Frayling TM, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Johnson T, Elliott P, Rybin D, Henneman P, Dehghan A, Hottenga JJ, Song K, Goel A, Egan JM, Lajunen T, Doney A, Kanoni S, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hicks AA, Hillman DR, Hingorani AD, Hui J, Hung J, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Manning AK, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Oostra BA, Orrù M, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Seedorf U, Sharp SJ, Shields B, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tanaka T, Tönjes A, Uitterlinden AG, van Dijk KW, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Ward KL, Watkins H, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Silander K, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7(1):e29202. PMID: 22238593; PMCID: PMC3251563.
    14. Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji ZS, Balestra ME, Walker DW, Xu Q, Jeong DE, Budamagunta MS, Voss JC, Freedman SB, Weisgraber KH, Huang Y, Mahley R. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 2012 Feb 17; 287(8):5253-66. PMID: 22158868; PMCID: PMC3285306.
    15. Hodoglugil U, Williamson DW, Yu Y, Farrer LA, Mahley R. Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks. Ann Hum Genet. 2011 May; 75(3):398-417. PMID: 21488854; PMCID: PMC3538863.
    16. Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong DE, Pleiss M, McComas C, Hess F, Witter D, Peterson S, Childers M, Goulet M, Liverton N, Hargreaves R, Freedman S, Weisgraber KH, Mahley R, Huang Y. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem. 2011 May 13; 286(19):17217-26. PMID: 21454574; PMCID: PMC3089564.
    17. Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley R. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem. 2011 Feb 18; 286(7):5215-21. PMID: 21118811; PMCID: PMC3037634.
    18. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesäniemi YA, Mahley R, Grundy SM, McArdle W, Cardon L, Waeber G, Vollenweider P, Chambers JC, Boehnke M, Abecasis GR, Salomaa V, Järvelin MR, Ruokonen A, Barroso I, Epstein SE, Hakonarson HH, Rader DJ, Reilly MP, Witteman JC, Hall AS, Samani NJ, Strachan DP, Barter P, van Duijn CM, Kooner JS, Peltonen L, Wareham NJ, McPherson R, Mooser V, Sandhu MS. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010 Nov; 30(11):2264-76. PMID: 20864672; PMCID: PMC3891568.
    19. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, Barroso I, Khaw KT, Grundy S, Barter P, Mahley R, Kesaniemi A, McPherson R, Vincent JB, Strauss J, Kennedy JL, Farmer A, McGuffin P, Day R, Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M, Brueckl T, Horstmann S, Wichmann HE, Rawal R, Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J, Campbell S, Kooner J, Chambers JC, Burnett MS, Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H, Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W, Hakonarson HH, Rader DJ, Franke A, Wittig M, Schäfer A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P, Schlessinger D, St Clair D, Rujescu D, Abecasis GR, Grabe HJ, Teumer A, Völzke H, Petersmann A, John U, Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ, Thompson JR, Balmforth AJ, Hall AS, Samani NJ, Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi J, Caulfield M, Munroe PB, Farrall M, Dominiczak A, Worthington J, Thomson W, Eyre S, Barton A, Mooser V, Francks C, Marchini J. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet. 2010 May; 42(5):436-40. PMID: 20418889; PMCID: PMC3612983.
    20. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Mägi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparsø T, Doney A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proença C, Kumari M, Qi L, Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jørgensen T, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martínez-Larrad MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orrù M, Pakyz R, Palmer CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tanaka T, Thorand B, Tichet J, Tönjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano-Ríos M, Morris AD, Lind L, Palmer LJ, Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, Groop L, Boehnke M, McCarthy MI, Florez JC, Barroso I. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010 Feb; 42(2):105-16. PMID: 20081858; PMCID: PMC3018764.
    21. Richards JB, Waterworth D, O'Rahilly S, Hivert MF, Loos RJ, Perry JR, Tanaka T, Timpson NJ, Semple RK, Soranzo N, Song K, Rocha N, Grundberg E, Dupuis J, Florez JC, Langenberg C, Prokopenko I, Saxena R, Sladek R, Aulchenko Y, Evans D, Waeber G, Erdmann J, Burnett MS, Sattar N, Devaney J, Willenborg C, Hingorani A, Witteman JC, Vollenweider P, Glaser B, Hengstenberg C, Ferrucci L, Melzer D, Stark K, Deanfield J, Winogradow J, Grassl M, Hall AS, Egan JM, Thompson JR, Ricketts SL, König IR, Reinhard W, Grundy S, Wichmann HE, Barter P, Mahley R, Kesaniemi YA, Rader DJ, Reilly MP, Epstein SE, Stewart AF, Van Duijn CM, Schunkert H, Burling K, Deloukas P, Pastinen T, Samani NJ, McPherson R, Davey Smith G, Frayling TM, Wareham NJ, Meigs JB, Mooser V, Spector TD. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009 Dec; 5(12):e1000768. PMID: 20011104; PMCID: PMC2781107.
    22. Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, Halabisky B, Deng C, Mahley R, Huang Y. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell. 2009 Dec 04; 5(6):634-45. PMID: 19951691; PMCID: PMC2992822.
    23. Hodoglugil U, Williamson DW, Mahley R. Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. J Lipid Res. 2010 Feb; 51(2):422-30. PMID: 19734193; PMCID: PMC2803245.
    24. Mahley R, Huang Y. Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches. Ann Neurol. 2009 Jun; 65(6):623-5. PMID: 19557874.
      View in: PubMed
    25. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell BD. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009 Apr; 17(4):737-44. PMID: 19165155; PMCID: PMC4028785.
    26. Mahley R, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res. 2009 Apr; 50 Suppl:S183-8. PMID: 19106071; PMCID: PMC2674716.
    27. Tanyolaç S, Mahley R, Hodoglugil U, Goldfine ID. Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population. Obesity (Silver Spring). 2008 Nov; 16(11):2468-71. PMID: 18719658; PMCID: PMC4486356.
    28. Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, Groth DF, Yehiely F, Korth C, Moore RC, Tatzelt J, Rubinstein E, Boucheix C, Yang X, Stanley P, Lisanti MP, Dwek RA, Rudd PM, Moskovitz J, Epstein CJ, Cruz TD, Kuziel WA, Maeda N, Sap J, Ashe KH, Carlson GA, Tesseur I, Wyss-Coray T, Mucke L, Weisgraber KH, Mahley R, Cohen FE, Prusiner SB. Genes contributing to prion pathogenesis. J Gen Virol. 2008 Jul; 89(Pt 7):1777-88. PMID: 18559949; PMCID: PMC2828448.
    29. Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley R, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A. 2008 Jun 24; 105(25):8718-23. PMID: 18562290; PMCID: PMC2438419.
    30. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JH, Song K, Yuan X, Johnson T, Ashford S, Inouye M, Luben R, Sims M, Hadley D, McArdle W, Barter P, Kesäniemi YA, Mahley R, McPherson R, Grundy SM, Bingham SA, Khaw KT, Loos RJ, Waeber G, Barroso I, Strachan DP, Deloukas P, Vollenweider P, Wareham NJ, Mooser V. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008 Feb 09; 371(9611):483-91. PMID: 18262040; PMCID: PMC2292820.
    31. Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley R, Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A. 2008 Jan 29; 105(4):1343-6. PMID: 18212130; PMCID: PMC2234140.
    32. Mahley R, Huang Y, Weisgraber KH. Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2007 Dec; 4(5):537-40. PMID: 18220516.
      View in: PubMed
    33. Stirnadel H, Lin X, Ling H, Song K, Barter P, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot T, Cohen J, Grundy S, Mitchell B, Mooser V, Waterworth D. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis. 2008 Apr; 197(2):868-76. PMID: 17888929.
      View in: PubMed
    34. Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, Bersot T, Mooser V, Waterworth D, Grundy SM. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab. 2007 Jun; 92(6):2041-5. PMID: 17389699.
      View in: PubMed
    35. Mahley R, Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest. 2007 Jan; 117(1):94-8. PMID: 17200713; PMCID: PMC1716223.
    36. Safar JG, Wille H, Geschwind MD, Deering C, Latawiec D, Serban A, King DJ, Legname G, Weisgraber KH, Mahley R, Miller BL, Dearmond SJ, Prusiner SB. Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11312-7. PMID: 16849426; PMCID: PMC1544083.
    37. Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley R. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J. 2007 Feb; 7(1):10-28. PMID: 16770341.
      View in: PubMed
    38. Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley R, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006 May 10; 26(19):4985-94. PMID: 16687490.
      View in: PubMed
    39. Mahley R, Huang Y, Weisgraber KH. Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest. 2006 May; 116(5):1226-9. PMID: 16670767; PMCID: PMC1451226.
    40. Huang Y, Mahley R. Commentary on "Perspective on a pathogenesis and treatment of Alzheimer's disease." Apolipoprotein E and the mitochondrial metabolic hypothesis. Alzheimers Dement. 2006 Apr; 2(2):71-3. PMID: 19595858.
      View in: PubMed
    41. Mahley R, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Apr 11; 103(15):5644-51. PMID: 16567625; PMCID: PMC1414631.
    42. Hodoglugil U, Mahley R. Smoking and obesity make a bad problem worse: genetics and lifestyle affect high density lipoprotein levels in Turks. Anadolu Kardiyol Derg. 2006 Mar; 6(1):60-7. PMID: 16524804.
      View in: PubMed
    43. Mahley R, Bersot TP. High density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kardiyol Derg. 2006 Mar; 6(1):94-6; author reply 96. PMID: 16524816.
      View in: PubMed
    44. Mahley R, Huang Y. Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurol Scand Suppl. 2006; 185:8-14. PMID: 16866905.
      View in: PubMed
    45. Ye S, Huang Y, Müllendorff K, Dong L, Giedt G, Meng EC, Cohen FE, Kuntz ID, Weisgraber KH, Mahley R. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18700-5. PMID: 16344478; PMCID: PMC1311738.
    46. Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley R, Huang Y. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18694-9. PMID: 16344479; PMCID: PMC1311737.
    47. Ji ZS, Müllendorff K, Cheng IH, Miranda RD, Huang Y, Mahley R. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J Biol Chem. 2006 Feb 03; 281(5):2683-92. PMID: 16298992.
      View in: PubMed
    48. Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley R. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res. 2006 Jan; 47(1):144-53. PMID: 16258166.
      View in: PubMed
    49. Mahley R, Can S, Ozbayrakçi S, Bersot TP, Tanir S, Palaoglu KE, Pépin GM. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol. 2005 Aug 15; 96(4):547-55. PMID: 16098310.
      View in: PubMed
    50. Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot TP, Ma Q, Sharma SS, Montgomery DS, Middleton LT, Sundseth SS, Mooser V, Grundy SM, Farrer LA. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res. 2005 Oct; 46(10):2202-13. PMID: 16061952.
      View in: PubMed
    51. Hodoglugil U, Williamson DW, Huang Y, Mahley R. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet. 2005 Aug; 68(2):118-27. PMID: 15996208.
      View in: PubMed
    52. Hodoglugil U, Williamson DW, Huang Y, Mahley R. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis. 2005 Dec; 183(2):199-212. PMID: 15935359.
      View in: PubMed
    53. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 Jan 15; 95(2):194-8. PMID: 15642551.
      View in: PubMed
    54. Harris FM, Brecht WJ, Xu Q, Mahley R, Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem. 2004 Oct 22; 279(43):44795-801. PMID: 15322121.
      View in: PubMed
    55. Xu Q, Brecht WJ, Weisgraber KH, Mahley R, Huang Y. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004 Jun 11; 279(24):25511-6. PMID: 15054100.
      View in: PubMed
    56. Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Dee Fish J, Wyss-Coray T, Buttini M, Mucke L, Mahley R, Huang Y. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004 Mar 10; 24(10):2527-34. PMID: 15014128.
      View in: PubMed
    57. Huang Y, Weisgraber KH, Mucke L, Mahley R. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci. 2004; 23(3):189-204. PMID: 15181247.
      View in: PubMed
    58. Bersot TP, Pépin GM, Mahley R. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J. 2003 Dec; 146(6):1052-9. PMID: 14660998.
      View in: PubMed
    59. Harris FM, Tesseur I, Brecht WJ, Xu Q, Mullendorff K, Chang S, Wyss-Coray T, Mahley R, Huang Y. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem. 2004 Jan 30; 279(5):3862-8. PMID: 14585838.
      View in: PubMed
    60. Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E, Hopkins PC, Scearce-Levie K, Weisgraber KH, Mucke L, Mahley R, Huang Y. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A. 2003 Sep 16; 100(19):10966-71. PMID: 12939405; PMCID: PMC196910.
    61. Bersot TP, Palaoglu KE, Mahley R. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol. Anadolu Kardiyol Derg. 2002 Dec; 2(4):315-22. PMID: 12460830.
      View in: PubMed
    62. Ludwig EH, Mahley R, Palaoglu E, Ozbayrakçi S, Balestra ME, Borecki IB, Innerarity TL, Farese RV. DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women. Clin Genet. 2002 Jul; 62(1):68-73. PMID: 12123490.
      View in: PubMed
    63. Shohet RV, Vega GL, Bersot TP, Mahley R, Grundy SM, Guerra R, Cohen JC. Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum Mutat. 2002 May; 19(5):536-42. PMID: 11968086.
      View in: PubMed
    64. Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley R. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem. 2002 Jun 14; 277(24):21821-8. PMID: 11912196.
      View in: PubMed
    65. Mahley R, Arslan P, Pekcan G, Pépin GM, Agaçdiken A, Karaagoglu N, Rakicioglu N, Nursal B, Dayanikli P, Palaoglu KE, Bersot TP. Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res. 2001 Dec; 42(12):1996-2006. PMID: 11734572.
      View in: PubMed
    66. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley R. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8838-43. PMID: 11447277; PMCID: PMC37522.
    67. Dichek HL, Johnson SM, Akeefe H, Lo GT, Sage E, Yap CE, Mahley R. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice. J Lipid Res. 2001 Feb; 42(2):201-10. PMID: 11181749.
      View in: PubMed
    68. Nguyen TT, Kruckeberg KE, O'Brien JF, Ji ZS, Karnes PS, Crotty TB, Hay ID, Mahley R, O'Brien T. Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)]. J Clin Endocrinol Metab. 2000 Nov; 85(11):4354-8. PMID: 11095479.
      View in: PubMed
    69. Mahley R, Pépin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res. 2000 Aug; 41(8):1290-301. PMID: 10946017.
      View in: PubMed
    70. Raber J, Wong D, Yu GQ, Buttini M, Mahley R, Pitas RE, Mucke L. Apolipoprotein E and cognitive performance. Nature. 2000 Mar 23; 404(6776):352-4. PMID: 10746713.
      View in: PubMed
    71. Langer C, Huang Y, Cullen P, Wiesenhütter B, Mahley R, Assmann G, von Eckardstein A. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. J Mol Med (Berl). 2000; 78(4):217-27. PMID: 10933584.
      View in: PubMed
    72. Mahley R, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000; 1:507-37. PMID: 11701639.
      View in: PubMed
    73. Buttini M, Akeefe H, Lin C, Mahley R, Pitas RE, Wyss-Coray T, Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 2000; 97(2):207-10. PMID: 10799751.
      View in: PubMed
    74. Huang Y, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley R. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Arterioscler Thromb Vasc Biol. 1999 Dec; 19(12):2952-9. PMID: 10591675.
      View in: PubMed
    75. Mahley R, Huang Y, Rall SC. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999 Nov; 40(11):1933-49. PMID: 10552997.
      View in: PubMed
    76. Mahley R, Rall SC. Is epsilon4 the ancestral human apoE allele? Neurobiol Aging. 1999 Jul-Aug; 20(4):429-30. PMID: 10604434.
      View in: PubMed
    77. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley R. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999 Jun 15; 19(12):4867-80. PMID: 10366621.
      View in: PubMed
    78. Mahley R, Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol. 1999 Jun; 10(3):207-17. PMID: 10431657.
      View in: PubMed
    79. Orth M, Weng W, Funke H, Steinmetz A, Assmann G, Nauck M, Dierkes J, Ambrosch A, Weisgraber KH, Mahley R, Wieland H, Luley C. Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites. Arterioscler Thromb Vasc Biol. 1999 May; 19(5):1306-15. PMID: 10323784.
      View in: PubMed
    80. Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagündüz P, Ozbayrakçi S, Gökdemir O, Mahley R. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res. 1999 Mar; 40(3):432-8. PMID: 10064731.
      View in: PubMed
    81. Mahley R, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999 Jan; 40(1):1-16. PMID: 9869645.
      View in: PubMed
    82. Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley R. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 1998 Oct 09; 273(41):26388-93. PMID: 9756870.
      View in: PubMed
    83. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley R, Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A. 1998 Sep 01; 95(18):10914-9. PMID: 9724804; PMCID: PMC27995.
    84. Huang Y, Liu XQ, Rall SC, Mahley R. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J Biol Chem. 1998 Jul 10; 273(28):17483-90. PMID: 9651338.
      View in: PubMed
    85. Vega GL, Gao J, Bersot TP, Mahley R, Verstraete R, Grundy SM, White A, Cohen JC. The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J Lipid Res. 1998 Jul; 39(7):1520-4. PMID: 9684756.
      View in: PubMed
    86. Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley R, Assmann G, von Eckardstein A. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. Proc Natl Acad Sci U S A. 1998 Jun 23; 95(13):7585-90. PMID: 9636193; PMCID: PMC22691.
    87. Ji ZS, Pitas RE, Mahley R. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. J Biol Chem. 1998 May 29; 273(22):13452-60. PMID: 9593678.
      View in: PubMed
    88. Fan J, Ji ZS, Huang Y, de Silva H, Sanan D, Mahley R, Innerarity TL, Taylor JM. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J Clin Invest. 1998 May 15; 101(10):2151-64. PMID: 9593771; PMCID: PMC508803.
    89. Pitas RE, Ji ZS, Weisgraber KH, Mahley R. Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E. Biochem Soc Trans. 1998 May; 26(2):257-62. PMID: 9649758.
      View in: PubMed
    90. Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley R. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J Biol Chem. 1998 Jan 23; 273(4):1896-903. PMID: 9442022.
      View in: PubMed
    91. Ji ZS, Dichek HL, Miranda RD, Mahley R. Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem. 1997 Dec 12; 272(50):31285-92. PMID: 9395455.
      View in: PubMed
    92. Huang Y, Rall SC, Mahley R. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler Thromb Vasc Biol. 1997 Nov; 17(11):2817-24. PMID: 9409260.
      View in: PubMed
    93. Huang Y, Schwendner SW, Rall SC, Sanan DA, Mahley R. Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J Biol Chem. 1997 Sep 05; 272(36):22685-94. PMID: 9312550.
      View in: PubMed
    94. Mahley R. The J. David Gladstone Institutes. Mol Med. 1997 Sep; 3(9):569-71. PMID: 9323707; PMCID: PMC2230087.
    95. Hussain MM, Goldberg IJ, Weisgraber KH, Mahley R, Innerarity TL. Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity. Arterioscler Thromb Vasc Biol. 1997 Jul; 17(7):1407-13. PMID: 9261274.
      View in: PubMed
    96. McGeer PL, Walker DG, Pitas RE, Mahley R, McGeer EG. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro. Brain Res. 1997 Feb 21; 749(1):135-8. PMID: 9070638.
      View in: PubMed
    97. Huang Y, Schwendner SW, Rall SC, Mahley R. Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. J Biol Chem. 1996 Nov 15; 271(46):29146-51. PMID: 8910571.
      View in: PubMed
    98. Weisgraber KH, Mahley R. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 1996 Nov; 10(13):1485-94. PMID: 8940294.
      View in: PubMed
    99. Mahley R. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr J Med Sci. 1996 Jun; 32(6):414-29. PMID: 8682647.
      View in: PubMed
    100. Mahley R, Nathan BP, Pitas RE. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Ann N Y Acad Sci. 1996 Jan 17; 777:139-45. PMID: 8624076.
      View in: PubMed
    101. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley R, Pitas RE. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 1995 Nov 10; 270(45):27063-71. PMID: 7592957.
      View in: PubMed
    102. Bellosta S, Mahley R, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest. 1995 Nov; 96(5):2170-9. PMID: 7593602; PMCID: PMC185866.
    103. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley R, Bu G, Schwartz AL. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci U S A. 1995 Oct 10; 92(21):9480-4. PMID: 7568158; PMCID: PMC40825.
    104. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley R, Pitas RE. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem. 1995 Aug 25; 270(34):19791-9. PMID: 7649988.
      View in: PubMed
    105. Hussain MM, Innerarity TL, Brecht WJ, Mahley R. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway. J Biol Chem. 1995 Apr 14; 270(15):8578-87. PMID: 7721759.
      View in: PubMed
    106. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley R, Vakar F. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995 Apr; 36(4):839-59. PMID: 7616127.
      View in: PubMed
    107. Mahley R, Nathan BP, Bellosta S, Pitas RE. Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr Opin Lipidol. 1995 Apr; 6(2):86-91. PMID: 7773573.
      View in: PubMed
    108. Ji ZS, Sanan DA, Mahley R. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J Lipid Res. 1995 Mar; 36(3):583-92. PMID: 7539827.
      View in: PubMed
    109. Ji ZS, Mahley R. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb. 1994 Dec; 14(12):2025-31. PMID: 7526899.
      View in: PubMed
    110. Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley R, Rall SC. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142). Arterioscler Thromb. 1994 Nov; 14(11):1873-9. PMID: 7947615.
      View in: PubMed
    111. Mahley R, Ji ZS, Brecht WJ, Miranda RD, He D. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann N Y Acad Sci. 1994 Sep 10; 737:39-52. PMID: 7944147.
      View in: PubMed
    112. Dong LM, Wilson C, Wardell MR, Simmons T, Mahley R, Weisgraber KH, Agard DA. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem. 1994 Sep 02; 269(35):22358-65. PMID: 8071364.
      View in: PubMed
    113. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley R, Taylor JM. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A. 1994 Aug 30; 91(18):8724-8. PMID: 8078949; PMCID: PMC44679.
    114. Wilson C, Mau T, Weisgraber KH, Wardell MR, Mahley R, Agard DA. Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure. 1994 Aug 15; 2(8):713-8. PMID: 7994571.
      View in: PubMed
    115. Lüttmann S, von Eckardstein A, Wei W, Funke H, Köhler E, Mahley R, Assmann G. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. J Lipid Res. 1994 Aug; 35(8):1431-40. PMID: 7989867.
      View in: PubMed
    116. Sanan DA, Weisgraber KH, Russell SJ, Mahley R, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994 Aug; 94(2):860-9. PMID: 8040342; PMCID: PMC296168.
    117. de Silva HV, Más-Oliva J, Taylor JM, Mahley R. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J Lipid Res. 1994 Jul; 35(7):1297-310. PMID: 7964191.
      View in: PubMed
    118. Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley R. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem. 1994 May 06; 269(18):13429-36. PMID: 8175774.
      View in: PubMed
    119. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley R, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994 May 06; 264(5160):850-2. PMID: 8171342.
      View in: PubMed
    120. Ji ZS, Fazio S, Mahley R. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem. 1994 May 06; 269(18):13421-8. PMID: 8175773.
      View in: PubMed
    121. Ji ZS, Fazio S, Lee YL, Mahley R. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem. 1994 Jan 28; 269(4):2764-72. PMID: 8300609.
      View in: PubMed
    122. de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley R, Taylor JM. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994 Jan 21; 269(3):2324-35. PMID: 8294490.
      View in: PubMed
    123. Chiesa G, Johnson DF, Yao Z, Innerarity TL, Mahley R, Young SG, Hammer RH, Hobbs HH. Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA. J Biol Chem. 1993 Nov 15; 268(32):23747-50. PMID: 8226902.
      View in: PubMed
    124. Lund-Katz S, Weisgraber KH, Mahley R, Phillips MC. Conformation of apolipoprotein E in lipoproteins. J Biol Chem. 1993 Nov 05; 268(31):23008-15. PMID: 8226815.
      View in: PubMed
    125. Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley R, Weisgraber KH, Innerarity TL, Fox CS. A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J Lipid Res. 1993 Jul; 34(7):1149-54. PMID: 8371062.
      View in: PubMed
    126. Thomas DL, Mahley R, Badur S, Palaoglu KE, Quinn TC. Epidemiology of hepatitis E virus infection in Turkey. Lancet. 1993 Jun 19; 341(8860):1561-2. PMID: 8099641.
      View in: PubMed
    127. Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley R. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 1993 May 15; 268(14):10160-7. PMID: 7683668.
      View in: PubMed
    128. de Silva HV, Lauer SJ, Mahley R, Weisgraber KH, Taylor JM. Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice. Biochem Soc Trans. 1993 May; 21(2):483-7. PMID: 8359515.
      View in: PubMed
    129. Schmidt EB, Illingworth DR, Bacon S, Russell SJ, Thatcher SR, Mahley R, Weisgraber KH. Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100. Metabolism. 1993 Feb; 42(2):137-9. PMID: 8474308.
      View in: PubMed
    130. Schmidt EB, Illingworth DR, Bacon S, Mahley R, Weisgraber KH. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100. Atherosclerosis. 1993 Jan 25; 98(2):213-7. PMID: 8457260.
      View in: PubMed
    131. Handelmann GE, Boyles JK, Weisgraber KH, Mahley R, Pitas RE. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res. 1992 Nov; 33(11):1677-88. PMID: 1464751.
      View in: PubMed
    132. Rall SC, Mahley R. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med. 1992 Jun; 231(6):653-9. PMID: 1619388.
      View in: PubMed
    133. Illingworth DR, Vakar F, Mahley R, Weisgraber KH. Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100. Lancet. 1992 Mar 07; 339(8793):598-600. PMID: 1347103.
      View in: PubMed
    134. Hussain MM, Maxfield FR, Más-Oliva J, Tabas I, Ji ZS, Innerarity TL, Mahley R. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem. 1991 Jul 25; 266(21):13936-40. PMID: 1713211.
      View in: PubMed
    135. Wilson C, Wardell MR, Weisgraber KH, Mahley R, Agard DA. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 1991 Jun 28; 252(5014):1817-22. PMID: 2063194.
      View in: PubMed
    136. Mahley R, Weisgraber KH, Innerarity TL, Rall SC. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. JAMA. 1991 Jan 02; 265(1):78-83. PMID: 1845776.
      View in: PubMed
    137. Weisgraber KH, Mahley R, Kowal RC, Herz J, Goldstein JL, Brown MS. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem. 1990 Dec 25; 265(36):22453-9. PMID: 2266137.
      View in: PubMed
    138. Innerarity TL, Mahley R, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res. 1990 Aug; 31(8):1337-49. PMID: 2280177.
      View in: PubMed
    139. Crook D, Weisgraber KH, Boyles JK, Mahley R. Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets. Arteriosclerosis. 1990 Jul-Aug; 10(4):633-47. PMID: 2114868.
      View in: PubMed
    140. Crook D, Weisgraber KH, Rall SC, Mahley R. Isolation and characterization of several plasma apolipoproteins of common marmoset monkey. Arteriosclerosis. 1990 Jul-Aug; 10(4):625-32. PMID: 2114867.
      View in: PubMed
    141. Kowal RC, Herz J, Weisgraber KH, Mahley R, Brown MS, Goldstein JL. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem. 1990 Jun 25; 265(18):10771-9. PMID: 2355022.
      View in: PubMed
    142. Weisgraber KH, Innerarity TL, Rall SC, Mahley R. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E. Ann N Y Acad Sci. 1990; 598:37-48. PMID: 2248450.
      View in: PubMed
    143. Hussain MM, Mahley R, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL. Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J Biol Chem. 1989 Oct 25; 264(30):17931-8. PMID: 2509449.
      View in: PubMed
    144. Steinberg D, Carew TE, Fielding C, Fogelman AM, Mahley R, Sniderman AD, Zilversmit DB. Lipoproteins and the pathogenesis of atherosclerosis. Circulation. 1989 Sep; 80(3):719-23. PMID: 2670321.
      View in: PubMed
    145. Hussain MM, Mahley R, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem. 1989 Jun 05; 264(16):9571-82. PMID: 2722852.
      View in: PubMed
    146. Mahley R, Weisgraber KH, Hussain MM, Greenman B, Fisher M, Vogel T, Gorecki M. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J Clin Invest. 1989 Jun; 83(6):2125-30. PMID: 2723074; PMCID: PMC303940.
    147. Lalazar A, Mahley R. Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions. J Biol Chem. 1989 May 25; 264(15):8447-50. PMID: 2542277.
      View in: PubMed
    148. Rall SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley R, Bersot TP. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J Clin Invest. 1989 Apr; 83(4):1095-101. PMID: 2539388; PMCID: PMC303794.
    149. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley R, Gebicke-Haerter PJ, Ignatius MJ. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989 Mar; 83(3):1015-31. PMID: 2493483; PMCID: PMC303779.
    150. Mahley R, Hui DY, Innerarity TL, Beisiegel U. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake. Arteriosclerosis. 1989 Jan-Feb; 9(1 Suppl):I14-8. PMID: 2536272.
      View in: PubMed
    151. Weisgraber KH, Newhouse YM, Taylor JM, Tuan B, Nestruck AC, Davignon J, Mahley R. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes. Arteriosclerosis. 1989 Jan-Feb; 9(1):50-7. PMID: 2912421.
      View in: PubMed
    152. Weisgraber KH, Newhouse YM, Mahley R. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes. Biochem Biophys Res Commun. 1988 Dec 30; 157(3):1212-7. PMID: 3207421.
      View in: PubMed
    153. Weisgraber KH, Innerarity TL, Newhouse YM, Young SG, Arnold KS, Krauss RM, Vega GL, Grundy SM, Mahley R. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9758-62. PMID: 3200853; PMCID: PMC282860.
    154. Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley R, Shooter EM, Gebicke-Haerter PJ. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol. 1988 Sep; 107(3):1207-13. PMID: 2458361; PMCID: PMC2115305.
    155. Aggerbeck LP, Wetterau JR, Weisgraber KH, Mahley R, Agard DA. Crystallization and preliminary X-ray diffraction studies on the amino-terminal (receptor-binding) domain of human apolipoprotein E3 from serum very low density lipoproteins. J Mol Biol. 1988 Jul 05; 202(1):179-81. PMID: 3172212.
      View in: PubMed
    156. Beisiegel U, Weber W, Havinga JR, Ihrke G, Hui DY, Wernette-Hammond ME, Turck CW, Innerarity TL, Mahley R. Apolipoprotein E-binding proteins isolated from dog and human liver. Arteriosclerosis. 1988 May-Jun; 8(3):288-97. PMID: 2835955.
      View in: PubMed
    157. Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, Bilheimer DW, Mahley R, Innerarity TL. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J Clin Invest. 1988 May; 81(5):1332-40. PMID: 3163347; PMCID: PMC442561.
    158. Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29; 240(4852):622-30. PMID: 3283935.
      View in: PubMed
    159. Lalazar A, Weisgraber KH, Rall SC, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley R. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem. 1988 Mar 15; 263(8):3542-5. PMID: 2831187.
      View in: PubMed
    160. Fainaru M, Funke H, Boyles JK, Ludwig EH, Innerarity TL, Mahley R. Metabolism of canine beta-very low density lipoproteins in normal and cholesterol-fed dogs. Arteriosclerosis. 1988 Mar-Apr; 8(2):130-9. PMID: 2831863.
      View in: PubMed
    161. Corsini A, Spilman CH, Innerarity TL, Arnold KS, Rall SC, Boyles JK, Mahley R. Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments. J Lipid Res. 1987 Dec; 28(12):1410-23. PMID: 2828500.
      View in: PubMed
    162. Innerarity TL, Young SG, Poksay KS, Mahley R, Smith RS, Milne RW, Marcel YL, Weisgraber KH. Structural relationship of human apolipoprotein B48 to apolipoprotein B100. J Clin Invest. 1987 Dec; 80(6):1794-8. PMID: 3680528; PMCID: PMC442455.
    163. Friedman G, Wernette-Hammond ME, Hui DY, Mahley R, Innerarity TL. Characterization of lipoprotein receptors on rat Fu5AH hepatoma cells. J Lipid Res. 1987 Dec; 28(12):1482-94. PMID: 2828502.
      View in: PubMed
    164. Innerarity TL, Weisgraber KH, Arnold KS, Mahley R, Krauss RM, Vega GL, Grundy SM. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987 Oct; 84(19):6919-23. PMID: 3477815; PMCID: PMC299196.
    165. Ludwig EH, Blackhart BD, Pierotti VR, Caiati L, Fortier C, Knott T, Scott J, Mahley R, Levy-Wilson B, McCarthy BJ. DNA sequence of the human apolipoprotein B gene. DNA. 1987 Aug; 6(4):363-72. PMID: 3652907.
      View in: PubMed
    166. Ignatius MJ, Shooter EM, Pitas RE, Mahley R. Lipoprotein uptake by neuronal growth cones in vitro. Science. 1987 May 22; 236(4804):959-62. PMID: 3576212.
      View in: PubMed
    167. Scott J, Pease RJ, Powell LM, Wallis SC, McCarthy BJ, Mahley R, Levy-Wilson B, Knott TJ. Human apolipoprotein B: complete cDNA sequence and identification of structural domains of the protein. Biochem Soc Trans. 1987 Apr; 15(2):195-9. PMID: 3556259.
      View in: PubMed
    168. Marcel YL, Innerarity TL, Spilman C, Mahley R, Protter AA, Milne RW. Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis. 1987 Mar-Apr; 7(2):166-75. PMID: 2437897.
      View in: PubMed
    169. Gebicke-Haerter PJ, Darby JK, Shooter EM, Riccardi VM, Weisgraber KH, Boyles JK, Mahley R. Apolipoprotein E synthesis in neurofibrosarcoma and schwannoma cell cultures from two individuals with neurofibromatosis. Exp Neurol. 1987 Feb; 95(2):323-35. PMID: 3100319.
      View in: PubMed
    170. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley R. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta. 1987 Jan 13; 917(1):148-61. PMID: 3539206.
      View in: PubMed
    171. Innerarity TL, Weisgraber KH, Rall SC, Mahley R. Functional domains of apolipoprotein E and apolipoprotein B. Acta Med Scand Suppl. 1987; 715:51-9. PMID: 3035881.
      View in: PubMed
    172. Scott J, Pease RJ, Powell LM, Wallis SC, McCarthy BJ, Mahley R, Levy-Wilson B, Knott TJ. Apolipoprotein B gene: plasma cholesterol and atherosclerosis. Biochem Soc Symp. 1987; 53:155-63. PMID: 3332766.
      View in: PubMed
    173. Mahley R. The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology. Clin Invest Med. 1986 Nov; 9(4):304-8. PMID: 3026707.
      View in: PubMed
    174. Knott TJ, Wallis SC, Powell LM, Pease RJ, Lusis AJ, Blackhart B, McCarthy BJ, Mahley R, Levy-Wilson B, Scott J. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 1986 Sep 25; 14(18):7501-3. PMID: 3763409; PMCID: PMC311765.
    175. Mahley R, Innerarity TL, Hui DY, Weisgraber KH, Pitas RE. Pathology: plasma cholesterol levels determined by lipoprotein interactions with cell surface receptors. West J Med. 1986 Sep; 145(3):372. PMID: 18750070.
      View in: PubMed
    176. Reardon CA, Lau YF, Paik YK, Weisgraber KH, Mahley R, Taylor JM. Expression of the human apolipoprotein E gene in cultured mammalian cells. J Biol Chem. 1986 Jul 25; 261(21):9858-64. PMID: 3733697.
      View in: PubMed
    177. Rall SC, Weisgraber KH, Mahley R, Ehnholm C, Schamaun O, Olaisen B, Blomhoff JP, Teisberg P. Identification of homozygosity for a human apolipoprotein A-I variant. J Lipid Res. 1986 Apr; 27(4):436-41. PMID: 3723016.
      View in: PubMed
    178. Hui DY, Brecht WJ, Hall EA, Friedman G, Innerarity TL, Mahley R. Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J Biol Chem. 1986 Mar 25; 261(9):4256-67. PMID: 3005328.
      View in: PubMed
    179. Weisgraber KH, Rall SC, Mahley R, Milne RW, Marcel YL, Sparrow JT. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem. 1986 Feb 15; 261(5):2068-76. PMID: 2418019.
      View in: PubMed
    180. Ignatius MJ, Gebicke-Härter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley R, Shooter EM. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A. 1986 Feb; 83(4):1125-9. PMID: 2419900; PMCID: PMC323024.
    181. Bersot TP, Innerarity TL, Pitas RE, Rall SC, Weisgraber KH, Mahley R. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest. 1986 Feb; 77(2):622-30. PMID: 2935560; PMCID: PMC423398.
    182. Rall SC, Weisgraber KH, Mahley R. Isolation and characterization of apolipoprotein E. Methods Enzymol. 1986; 128:273-87. PMID: 3724506.
      View in: PubMed
    183. Weisgraber KH, Mahley R. Characterization of apolipoprotein E-containing lipoproteins. Methods Enzymol. 1986; 129:145-66. PMID: 3724537.
      View in: PubMed
    184. Innerarity TL, Pitas RE, Mahley R. Lipoprotein-receptor interactions. Methods Enzymol. 1986; 129:542-65. PMID: 2425225.
      View in: PubMed
    185. Innerarity TL, Hui DY, Bersot TP, Mahley R. Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions. Adv Exp Med Biol. 1986; 201:273-88. PMID: 3026150.
      View in: PubMed
    186. Taylor JM, Mahley R, Fukazawa C. Cloning of the cDNA for rat and human apolipoprotein E mRNA. Methods Enzymol. 1986; 128:801-11. PMID: 2425224.
      View in: PubMed
    187. Reardon CA, Paik YK, Chang DJ, Davies GE, Mahley R, Lau YF, Taylor JM. Cloning and expression of the human apolipoprotein E gene. Methods Enzymol. 1986; 128:811-23. PMID: 3014273.
      View in: PubMed
    188. Mahley R, Innerarity TL, Weisgraber KH, Rall SC, Hui DY, Lalazar A, Boyles JK, Taylor JM, Levy-Wilson B. Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interactions. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:821-8. PMID: 3034497.
      View in: PubMed
    189. Innerarity TL, Arnold KS, Weisgraber KH, Mahley R. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages. Arteriosclerosis. 1986 Jan-Feb; 6(1):114-22. PMID: 3942555.
      View in: PubMed
    190. Weisgraber KH, Newhouse YM, Seymour JL, Rall SC, Mahley R. Preparative immobiline isoelectric focusing of plasma apolipoproteins on vertical slab gels. Anal Biochem. 1985 Dec; 151(2):455-61. PMID: 4096384.
      View in: PubMed
    191. Mahley R. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. Circulation. 1985 Nov; 72(5):943-8. PMID: 4042302.
      View in: PubMed
    192. Koo C, Innerarity TL, Mahley R. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem. 1985 Oct 05; 260(22):11934-43. PMID: 2995353.
      View in: PubMed
    193. Boyles JK, Pitas RE, Wilson E, Mahley R, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985 Oct; 76(4):1501-13. PMID: 3932467; PMCID: PMC424114.
    194. Cornhill JF, Barrett WA, Herderick EE, Mahley R, Fry DL. Topographic study of sudanophilic lesions in cholesterol-fed minipigs by image analysis. Arteriosclerosis. 1985 Sep-Oct; 5(5):415-26. PMID: 2412537.
      View in: PubMed
    195. Weisgraber KH, Innerarity TL, Rall SC, Mahley R. Receptor interactions controlling lipoprotein metabolism. Can J Biochem Cell Biol. 1985 Aug; 63(8):898-905. PMID: 2998579.
      View in: PubMed
    196. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley R, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A. 1985 May; 82(10):3445-9. PMID: 2987927; PMCID: PMC397792.
    197. Weisgraber KH, Innerarity TL, Rall SC, Mahley R. Apolipoprotein E: receptor binding properties. Adv Exp Med Biol. 1985; 183:159-71. PMID: 2412412.
      View in: PubMed
    198. Mahley R, Innerarity TL, Rall SC, Weisgraber KH. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia. Ann N Y Acad Sci. 1985; 454:209-21. PMID: 3000263.
      View in: PubMed
    199. Elshourbagy NA, Liao WS, Mahley R, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A. 1985 Jan; 82(1):203-7. PMID: 3918303; PMCID: PMC397000.
    200. Pitas RE, Boyles J, Mahley R, Bissell DM. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J Cell Biol. 1985 Jan; 100(1):103-17. PMID: 3965468; PMCID: PMC2113470.
    201. Hui DY, Innerarity TL, Milne RW, Marcel YL, Mahley R. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem. 1984 Dec 25; 259(24):15060-8. PMID: 6096356.
      View in: PubMed
    202. Mahley R, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984 Dec 01; 25(12):1277-94. PMID: 6099394.
      View in: PubMed
    203. Utermann G, Haas J, Steinmetz A, Paetzold R, Rall SC, Weisgraber KH, Mahley R. Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase. Eur J Biochem. 1984 Oct 15; 144(2):325-31. PMID: 6489332.
      View in: PubMed
    204. Ehnholm C, Mahley R, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A. 1984 Sep; 81(17):5566-70. PMID: 6591204; PMCID: PMC391747.
    205. Funke H, Boyles J, Weisgraber KH, Ludwig EH, Hui DY, Mahley R. Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells. Arteriosclerosis. 1984 Sep-Oct; 4(5):452-61. PMID: 6089725.
      View in: PubMed
    206. Rall SC, Weisgraber KH, Mahley R, Ogawa Y, Fielding CJ, Utermann G, Haas J, Steinmetz A, Menzel HJ, Assmann G. Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted. J Biol Chem. 1984 Aug 25; 259(16):10063-70. PMID: 6432779.
      View in: PubMed
    207. Innerarity TL, Weisgraber KH, Arnold KS, Rall SC, Mahley R. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. J Biol Chem. 1984 Jun 10; 259(11):7261-7. PMID: 6327714.
      View in: PubMed
    208. McLean JW, Elshourbagy NA, Chang DJ, Mahley R, Taylor JM. Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem. 1984 May 25; 259(10):6498-504. PMID: 6327682.
      View in: PubMed
    209. Utermann G, Weisgraber KH, Weber W, Mahley R. Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis. J Lipid Res. 1984 Apr; 25(4):378-82. PMID: 6726088.
      View in: PubMed
    210. Weisgraber KH, Rall SC, Innerarity TL, Mahley R, Kuusi T, Ehnholm C. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. J Clin Invest. 1984 Apr; 73(4):1024-33. PMID: 6323533; PMCID: PMC425115.
    211. Menzel HJ, Assmann G, Rall SC, Weisgraber KH, Mahley R. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. J Biol Chem. 1984 Mar 10; 259(5):3070-6. PMID: 6421816.
      View in: PubMed
    212. Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley R. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Metabolism. 1984 Feb; 33(2):186-95. PMID: 6319954.
      View in: PubMed
    213. Hui DY, Innerarity TL, Mahley R. Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E. J Biol Chem. 1984 Jan 25; 259(2):860-9. PMID: 6319389.
      View in: PubMed
    214. Steinmetz A, Utermann G, Haas J, Menzel HJ, Rall SC, Weisgraber KH, Mahley R. Mutations of apolipoprotein AI can affect cofactor function for cholesteryl ester formation by lecithin: cholesterol acyltransferase. Agents Actions Suppl. 1984; 16:217-24. PMID: 6435410.
      View in: PubMed
    215. Mahley R, Angelin B. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv Intern Med. 1984; 29:385-411. PMID: 6369930.
      View in: PubMed
    216. Weisgraber KH, Innerarity TL, Harder KJ, Mahley R, Milne RW, Marcel YL, Sparrow JT. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem. 1983 Oct 25; 258(20):12348-54. PMID: 6313653.
      View in: PubMed
    217. Innerarity TL, Friedlander EJ, Rall SC, Weisgraber KH, Mahley R. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem. 1983 Oct 25; 258(20):12341-7. PMID: 6313652.
      View in: PubMed
    218. Schmitz G, Assmann G, Rall SC, Mahley R. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins. Proc Natl Acad Sci U S A. 1983 Oct; 80(19):6081-5. PMID: 6412234; PMCID: PMC534364.
    219. Rall SC, Weisgraber KH, Innerarity TL, Bersot TP, Mahley R, Blum CB. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J Clin Invest. 1983 Oct; 72(4):1288-97. PMID: 6313758; PMCID: PMC370413.
    220. Bersot TP, Innerarity TL, Mahley R, Havel RJ. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia. J Clin Invest. 1983 Sep; 72(3):1024-33. PMID: 6309903; PMCID: PMC1129269.
    221. Mahley R. Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies. Arch Pathol Lab Med. 1983 Aug; 107(8):393-9. PMID: 6307210.
      View in: PubMed
    222. Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R, Mahley R, Havel RJ. Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1983 Jun; 1(6):1453-60. PMID: 6304174.
      View in: PubMed
    223. Gordon V, Innerarity TL, Mahley R. Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem. 1983 May 25; 258(10):6202-12. PMID: 6343371.
      View in: PubMed
    224. Mahley R, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 1983 May 24; 737(2):197-222. PMID: 6303423.
      View in: PubMed
    225. Rall SC, Weisgraber KH, Innerarity TL, Mahley R. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia. J Clin Invest. 1983 Apr; 71(4):1023-31. PMID: 6300187; PMCID: PMC436959.
    226. Angelin B, Raviola CA, Innerarity TL, Mahley R. Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids. J Clin Invest. 1983 Apr; 71(4):816-31. PMID: 6300188; PMCID: PMC436938.
    227. Mahley R. Apolipoprotein E and cholesterol metabolism. Klin Wochenschr. 1983 Mar 01; 61(5):225-32. PMID: 6843048.
      View in: PubMed
    228. Weisgraber KH, Rall SC, Bersot TP, Mahley R, Franceschini G, Sirtori CR. Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem. 1983 Feb 25; 258(4):2508-13. PMID: 6401735.
      View in: PubMed
    229. Pitas RE, Innerarity TL, Mahley R. Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins. Arteriosclerosis. 1983 Jan-Feb; 3(1):2-12. PMID: 6297442.
      View in: PubMed
    230. Zannis VI, Breslow JL, Utermann G, Mahley R, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR, Blum C. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res. 1982 Aug; 23(6):911-4. PMID: 7130859.
      View in: PubMed
    231. Rall SC, Weisgraber KH, Innerarity TL, Mahley R. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A. 1982 Aug; 79(15):4696-700. PMID: 6289314; PMCID: PMC346743.
    232. Fainaru M, Mahley R, Hamilton RL, Innerarity TL. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res. 1982 Jul; 23(5):702-14. PMID: 7119569.
      View in: PubMed
    233. Reitman JS, Mahley R, Fry DL. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis. 1982 May; 43(1):119-32. PMID: 7092978.
      View in: PubMed
    234. Rall SC, Weisgraber KH, Mahley R. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem. 1982 Apr 25; 257(8):4171-8. PMID: 7068630.
      View in: PubMed
    235. Weisgraber KH, Innerarity TL, Mahley R. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982 Mar 10; 257(5):2518-21. PMID: 6277903.
      View in: PubMed
    236. Mahley R. Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin North Am. 1982 Mar; 66(2):375-402. PMID: 7040843.
      View in: PubMed
    237. Innerarity TL, Pitas RE, Mahley R. Modulating effects of canine high density lipoproteins on cholesteryl ester synthesis induced by beta-very low density lipoproteins in macrophages. Possible in vitro correlates with atherosclerosis. Arteriosclerosis. 1982 Mar-Apr; 2(2):114-24. PMID: 7065981.
      View in: PubMed
    238. Mahley R, Hui DY, Innerarity TL, Weisgraber KH. Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors. J Clin Invest. 1981 Nov; 68(5):1197-206. PMID: 6271808; PMCID: PMC370914.
    239. Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley R. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest. 1981 Oct; 68(4):1075-85. PMID: 6270194; PMCID: PMC370895.
    240. Weisgraber KH, Rall SC, Mahley R. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981 Sep 10; 256(17):9077-83. PMID: 7263700.
      View in: PubMed
    241. Innerarity TL, Kempner ES, Hui DY, Mahley R. Functional unit of the low density lipoprotein receptor of fibroblasts: a 100,000-dalton structure with multiple binding sites. Proc Natl Acad Sci U S A. 1981 Jul; 78(7):4378-82. PMID: 6270675; PMCID: PMC319793.
    242. Hui DY, Innerarity TL, Mahley R. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J Biol Chem. 1981 Jun 10; 256(11):5646-55. PMID: 6263887.
      View in: PubMed
    243. Pitas RE, Innerarity TL, Weinstein JN, Mahley R. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1981 May-Jun; 1(3):177-85. PMID: 6895305.
      View in: PubMed
    244. Melchior GW, Mahley R, Buckhold DK. Chylomicron metabolism during dietary-induced hypercholesterolemia in dogs. J Lipid Res. 1981 May; 22(4):598-609. PMID: 7276736.
      View in: PubMed
    245. Fry DL, Mahley R, Oh SY. Effect of arterial stretch on transmural albumin and Evan's blue dye transport. Am J Physiol. 1981 Apr; 240(4):H645-9. PMID: 7223913.
      View in: PubMed
    246. Fry DL, Mahley R, Oh SY, Swyt CR. Aortic transmural serum protein transport: effect of concentration, time, and location. Am J Physiol. 1981 Jan; 240(1):H54-61. PMID: 7457622.
      View in: PubMed
    247. Mahley R. The role of dietary fat and cholesterol in atherosclerosis and lipoprotein metabolism. West J Med. 1981 Jan; 134(1):34-42. PMID: 7210661; PMCID: PMC1272446.
    248. Mahley R. Cellular and molecular biology of lipoprotein metabolism in atherosclerosis. Diabetes. 1981; 30(Suppl 2):60-5. PMID: 7297774.
      View in: PubMed
    249. Hui DY, Harmony JA, Innerarity TL, Mahley R. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J Biol Chem. 1980 Dec 25; 255(24):11775-81. PMID: 7440569.
      View in: PubMed
    250. Innerarity TL, Pitas RE, Mahley R. Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity. J Biol Chem. 1980 Dec 10; 255(23):11163-72. PMID: 6254962.
      View in: PubMed
    251. Mahley R, Innerarity TL, Brown MS, Ho YK, Goldstein JL. Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res. 1980 Nov; 21(8):970-80. PMID: 7462813.
      View in: PubMed
    252. Franceschini G, Sirtori CR, Capurso A, Weisgraber KH, Mahley R. A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest. 1980 Nov; 66(5):892-900. PMID: 7430351; PMCID: PMC371523.
    253. Weisgraber KH, Bersot TP, Mahley R, Franceschini G, Sirtori CR. A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest. 1980 Nov; 66(5):901-7. PMID: 6776144; PMCID: PMC371524.
    254. Pitas RE, Nelson GJ, Mahley R. Effect of cholesterol supplementation of diets of thyroidectomized dogs on the fatty acid composition of erythrocyte phospholipids and plasma phosphatidylcholine. Biochim Biophys Acta. 1980 Sep 08; 619(3):699-704. PMID: 7459375.
      View in: PubMed
    255. Innerarity TL, Pitas RE, Mahley R. Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus. Biochemistry. 1980 Sep 02; 19(18):4359-65. PMID: 7417411.
      View in: PubMed
    256. Fry DL, Mahley R, Oh SY, Lewis SJ, Plowman F, Swyt CR. Quantitative microautoradiography of arteries: comparison of radioactivity to silver. Am J Physiol. 1980 Aug; 239(2):H289-95. PMID: 6250414.
      View in: PubMed
    257. Weisgraber KH, Troxler RF, Rall SC, Mahley R. Comparison of the human, canine and swine E apoproteins. Biochem Biophys Res Commun. 1980 Jul 16; 95(1):374-80. PMID: 7417263.
      View in: PubMed
    258. Pitas RE, Innerarity TL, Mahley R. Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem. 1980 Jun 10; 255(11):5454-60. PMID: 7372644.
      View in: PubMed
    259. Sherrill BC, Innerarity TL, Mahley R. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem. 1980 Mar 10; 255(5):1804-7. PMID: 7354059.
      View in: PubMed
    260. Goldstein JL, Ho YK, Brown MS, Innerarity TL, Mahley R. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J Biol Chem. 1980 Mar 10; 255(5):1839-48. PMID: 7354064.
      View in: PubMed
    261. Weisgraber KH, Mahley R. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res. 1980 Mar; 21(3):316-25. PMID: 7381326.
      View in: PubMed
    262. Mahley R, Johnson DK, Pucak GJ, Fry DL. Atherosclerosis in the Erythrocebus patas, an old world monkey. Am J Pathol. 1980 Feb; 98(2):401-24. PMID: 6766672; PMCID: PMC1903425.
    263. Mahley R, Innerarity TL, Weisgraber KH. Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins. Ann N Y Acad Sci. 1980; 348:265-80. PMID: 6994562.
      View in: PubMed
    264. Mahley R, Weisgraber KH, Melchior GW, Innerarity TL, Holcombe KS. Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. Proc Natl Acad Sci U S A. 1980 Jan; 77(1):225-9. PMID: 6767236; PMCID: PMC348241.
    265. Reitman JS, Mahley R. Changes induced in the lipoproteins of Yucatan miniature swine by cholesterol feeding. Biochim Biophys Acta. 1979 Dec 18; 575(3):446-57. PMID: 518896.
      View in: PubMed
    266. Mahley R, Weisgraber KH, Innerarity TL. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim Biophys Acta. 1979 Oct 26; 575(1):81-91. PMID: 228738.
      View in: PubMed
    267. Mahley R, Innerarity TL, Weisgraber KB, Oh SY. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J Clin Invest. 1979 Sep; 64(3):743-50. PMID: 224077; PMCID: PMC372176.
    268. Innerarity TL, Pitas RE, Mahley R. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem. 1979 May 25; 254(10):4186-90. PMID: 220235.
      View in: PubMed
    269. Pitas RE, Innerarity TL, Arnold KS, Mahley R. Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc. Proc Natl Acad Sci U S A. 1979 May; 76(5):2311-5. PMID: 221921; PMCID: PMC383590.
    270. Pitas RE, Nelson GJ, Jaffe RM, Mahley R. Effects of diets high in saturated fat and cholesterol on the lipid composition of canine platelets. Lipids. 1979 May; 14(5):469-77. PMID: 459712.
      View in: PubMed
    271. Mahley R, Weisgraber KH, Innerarity TL, Windmueller HG. Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residues. Proc Natl Acad Sci U S A. 1979 Apr; 76(4):1746-50. PMID: 221905; PMCID: PMC383467.
    272. Weisgraber KH, Innerarity TL, Mahley R. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem. 1978 Dec 25; 253(24):9053-62. PMID: 214439.
      View in: PubMed
    273. Weisgraber KH, Bersot TP, Mahley R. Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein. Biochem Biophys Res Commun. 1978 Nov 14; 85(1):287-92. PMID: 217374.
      View in: PubMed
    274. Mahley R, Innerarity TL, Bersot TP, Lipson A, Margolis S. Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol. Lancet. 1978 Oct 14; 2(8094):807-9. PMID: 81362.
      View in: PubMed
    275. Atkinson D, Tall AR, Small DM, Mahley R. Structural organization of the lipoprotein HDLc from atherosclerotic swine. Structural features relating the particle surface and core. Biochemistry. 1978 Sep 19; 17(19):3930-3. PMID: 213098.
      View in: PubMed
    276. Weisgraber KH, Mahley R. Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem. 1978 Sep 10; 253(17):6281-8. PMID: 210174.
      View in: PubMed
    277. Innerarity TL, Mahley R, Weisgraber KH, Bersot TP. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J Biol Chem. 1978 Sep 10; 253(17):6289-95. PMID: 210175.
      View in: PubMed
    278. Pitas RE, Nelson GJ, Jaffe RM, Mahley R. delta 15,18-tetracosadienoic acid content of sphingolipids from platelets and erythrocytes of animals fed diets high in saturated or polyunsaturated fats. Lipids. 1978 Aug; 13(8):551-6. PMID: 703532.
      View in: PubMed
    279. Innerarity TL, Mahley R. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 1978 Apr 18; 17(8):1440-7. PMID: 206278.
      View in: PubMed
    280. Mahley R, Innerarity TL. Properties of lipoproteins responsible for high affinity binding to cell surface receptors of fibroblasts and smooth muscle cells. Adv Exp Med Biol. 1978; 109:99-127. PMID: 364953.
      View in: PubMed
    281. Mahley R, Innerarity TL, Pitas RE, Weisgraber KH, Brown JH, Gross E. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J Biol Chem. 1977 Oct 25; 252(20):7279-87. PMID: 198407.
      View in: PubMed
    282. Tall AR, Atkinson D, Small DM, Mahley R. Characterization of the lipoproteins of atherosclerotic swine. J Biol Chem. 1977 Oct 25; 252(20):7288-93. PMID: 198408.
      View in: PubMed
    283. Weisgraber KH, Mahley R, Assmann G. The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats. Atherosclerosis. 1977 Oct; 28(2):121-40. PMID: 199205.
      View in: PubMed
    284. Fry DL, Mahley R, Weisgraber KH, Oh SY. Simultaneous accumulation of Evans blue dye and albumin in the canine aortic wall. Am J Physiol. 1977 Jul; 233(1):H66-79. PMID: 879338.
      View in: PubMed
    285. Mahley R, Innerarity TL. Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin/manganese precipitability. J Biol Chem. 1977 Jun 10; 252(11):3980-6. PMID: 193851.
      View in: PubMed
    286. Mahley R, Holcombe KS. Alterations of the plasma lipoproteins and apoproteins following cholesterol feeding in the rat. J Lipid Res. 1977 May; 18(3):314-24. PMID: 194008.
      View in: PubMed
    287. Mahley R, Innerarity TL, Weisgraber KH, Fry DL. Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro. Am J Pathol. 1977 Apr; 87(1):205-26. PMID: 192082; PMCID: PMC2032077.
    288. Mahley R. Lipoproteins and arterial smooth muscle cells: regulation of cellular metabolism by swine lipoproteins. Adv Exp Med Biol. 1977; 82:909-14. PMID: 920447.
      View in: PubMed
    289. Brown BG, Mahley R, Assmann G. Swine aortic smooth muscle in tissue culture. Some effects of purified swine lipoproteins on cell growth and morphology. Circ Res. 1976 Sep; 39(3):415-24. PMID: 182413.
      View in: PubMed
    290. Mahley R, Weisgraber KH, Innerarity T. Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey. Biochemistry. 1976 Jul 13; 15(14):2979-85. PMID: 182200.
      View in: PubMed
    291. Mahley R, Nelson AW, Ferrans VJ, Fry DL. Thrombosis in association with atherosclerosis induced by dietary perturbations in dogs. Science. 1976 Jun 11; 192(4244):1139-41. PMID: 1273587.
      View in: PubMed
    292. Mahley R, Weisgraber KH, Innerarity T, Brewer HB. Characterization of the plasma lipoproteins and apoproteins of the Erythrocebus patas monkey. Biochemistry. 1976 May 04; 15(9):1928-33. PMID: 178359.
      View in: PubMed
    293. Bersot TP, Mahley R, Brown MS, Goldstein JL. Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts. J Biol Chem. 1976 Apr 25; 251(8):2395-8. PMID: 177413.
      View in: PubMed
    294. Mahley R, Weisgraber KH, Innerarity T, Brewer HB, Assmann G. Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry. 1975 Jul; 14(13):2817-23. PMID: 167808.
      View in: PubMed
    295. Mahley R, Weisgraber KH, Innerarity T. Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia. Circ Res. 1974 Nov; 35(5):722-33. PMID: 4138629.
      View in: PubMed
    296. Mahley R, Weisgraber KH. Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs. Circ Res. 1974 Nov; 35(5):713-21. PMID: 4138628.
      View in: PubMed
    297. Wetmore S, Mahley R, Brown WV, Schachter H. Incorporation of sialic acid into sialidase-treated apolipoprotein of human, very low density lipoprotein by a pork liver sialytransferase. Can J Biochem. 1974 Aug; 52(8):654-64. PMID: 4373146.
      View in: PubMed
    298. Mahley R, Weisgraber KH. An electrophoretic method for the quantitative isolation of human and swine plasma lipoproteins. Biochemistry. 1974 Apr 23; 13(9):1964-9. PMID: 4366269.
      View in: PubMed
    299. Assmann G, Mahley R, Davis B, Holcombe KS. Cholesterol esterification by the rat liver Golgi apparatus. Scand J Clin Lab Invest Suppl. 1974; 137:23-8. PMID: 4367598.
      View in: PubMed
    300. Mahley R, Gray ME, LeQuire VS. Role of plasma lipoproteins in cortisone-induced fat embolism. Am J Pathol. 1972 Jan; 66(1):43-64. PMID: 5009252; PMCID: PMC2032473.
    301. Mahley R, Bennett BD, Morré DJ, Gray ME, Thistlethwaite W, LeQuire VS. Lipoproteins associated with the Golgi apparatus isolated from epithelial cells of rat small intestine. Lab Invest. 1971 Nov; 25(5):435-44. PMID: 4109439.
      View in: PubMed
    302. Mahley R, Bersot TP, LeQuire VS, Levy RI, Windmueller HG, Brown WV. Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus. Science. 1970 Apr 17; 168(3929):380-2. PMID: 4985196.
      View in: PubMed
    303. Engel E, Culbertson JC, Mahley R, Fenichel GM. Barr body studies from the hair. Lancet. 1970 Apr 11; 1(7650):789. PMID: 4191300.
      View in: PubMed
    304. Morré DJ, Hamilton RL, Mollenhauer HH, Mahley R, Cunningham WP, Cheetham RD, Lequire VS. Isolation of a Golgi apparatus-rich fraction from rat liver. I. Method and morphology. J Cell Biol. 1970 Mar; 44(3):484-91. PMID: 4905956; PMCID: PMC2107968.
    305. Mahley R, Hamilton RL, Lequire VS. Characterization of lipoprotein particles isolated from the Golgi apparatus of rat liver. J Lipid Res. 1969 Jul; 10(4):433-9. PMID: 4978881.
      View in: PubMed
    306. Mahley R, Gray ME, Hamilton RL, LeQuire VS. Lipid transport in liver. II. Electron microscopic and biochemical studies of alterations in lipoprotein transport induced by cortisone in the rabbit. Lab Invest. 1968 Oct; 19(4):358-69. PMID: 5699116.
      View in: PubMed
    Robert's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP